Neurological issues in children with COVID-19

JE Lin, A Asfour, TB Sewell, B Hooe, P Pryce… - Neuroscience …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) usually leads to a mild infectious disease
course in children, but serious complications may occur in conjunction with both acute …

Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system

MG Lazzaroni, S Piantoni, S Masneri, E Garrafa… - Blood reviews, 2021 - Elsevier
COVID-19 is a new pandemic, caused by Severe Acute Respiratory Syndrome-CoronaVirus-
2 (SARS-Cov2) infection and characterized by a broad spectrum of clinical manifestations …

Long-lasting cognitive abnormalities after COVID-19

R Ferrucci, M Dini, E Groppo, C Rosci, MR Reitano… - Brain sciences, 2021 - mdpi.com
Considering the mechanisms capable of causing brain alterations in COVID-19, we aimed to
study the occurrence of cognitive abnormalities in the months following hospital discharge …

ACE2: the molecular doorway to SARS-CoV-2

MM Medina-Enríquez, S Lopez-León… - Cell & bioscience, 2020 - Springer
The angiotensin-converting enzyme 2 (ACE2) is the host functional receptor for the new
virus SARS-CoV-2 causing Coronavirus Disease 2019. ACE2 is expressed in 72 different …

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: one year later

F Angeli, M Zappa, G Reboldi, M Trapasso… - European journal of …, 2021 - Elsevier
The pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-
2) generated much interest on the basic pathogenetic mechanisms through which SARS …

Neurological effects of COVID‐19 in infants and children

CE Stafstrom - Developmental Medicine & Child Neurology, 2022 - Wiley Online Library
Neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) in children are becoming increasingly apparent as the coronavirus disease (COVID …

[HTML][HTML] ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among …

SG Ramos, BA da Cruz Rattis, G Ottaviani… - The American journal of …, 2021 - Elsevier
Abstract SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the etiological
agent of COVID-19 (coronavirus disease 2019) and the cause of the current pandemic …

SARS-CoV-2 poorly replicates in cells of the human blood-brain barrier without associated deleterious effects

O Constant, J Barthelemy, K Bollore, E Tuaillon… - Frontiers in …, 2021 - frontiersin.org
Various neurological symptoms have been associated to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection including headache, fever, anosmia, ageusia, but …

Anti-infective, anti-inflammatory, and immunomodulatory properties of breast milk factors for the protection of infants in the pandemic from COVID-19

PA Quitadamo, L Comegna, P Cristalli - Frontiers in Public Health, 2021 - frontiersin.org
COVID-19 pandemic since the end of 2019 spreads worldwide, counting millions of victims.
The viral invasion, systemic inflammation, and consequent organ failure are the gravest …

Acute viral illnesses and ischemic stroke: pathophysiological considerations in the era of the COVID-19 pandemic

MN Bahouth, A Venkatesan - Stroke, 2021 - Am Heart Assoc
The severe acute respiratory syndrome coronavirus 2 or coronavirus disease 2019 (COVID-
19) pandemic has raised concerns about the correlation with this viral illness and increased …